bb2121 in RRMM patients, phase 1 (NCT02658929). Status: active, not recruiting.bb2121 in RRMM patients, phase 2 (NCT03361748). Status: recruiting.Anti-BCMA CAR-T for heavily pretreated MM patients, phase 1 (NCT02215967). Status: active, not recruiting.Combination of anti-BCMA CAR-T with lenalidomide in RRMM patients, phase 1 (NCT03070327). Status: recruiting. The gene discussed is TNFRSF17; the disease is Miyoshi myopathy.